FI115911B - Fuusioidut pyrrolokarbatsolit, menetelmä niiden valmistamiseksi ja niiden käyttö - Google Patents
Fuusioidut pyrrolokarbatsolit, menetelmä niiden valmistamiseksi ja niiden käyttö Download PDFInfo
- Publication number
- FI115911B FI115911B FI971479A FI971479A FI115911B FI 115911 B FI115911 B FI 115911B FI 971479 A FI971479 A FI 971479A FI 971479 A FI971479 A FI 971479A FI 115911 B FI115911 B FI 115911B
- Authority
- FI
- Finland
- Prior art keywords
- pyrrolo
- alkyl
- compound
- med
- eller
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Dermatology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32375594 | 1994-10-14 | ||
US08/323,755 US5475110A (en) | 1994-10-14 | 1994-10-14 | Fused Pyrrolocarbazoles |
US08/427,160 US5591855A (en) | 1994-10-14 | 1995-04-24 | Fused pyrrolocarbazoles |
US42716095 | 1995-04-24 | ||
US08/452,335 US5594009A (en) | 1994-10-14 | 1995-05-26 | Fused pyrrolocarbazoles |
US45233595 | 1995-05-26 | ||
US52679895 | 1995-09-11 | ||
US08/526,798 US5705511A (en) | 1994-10-14 | 1995-09-11 | Fused pyrrolocarbazoles |
PCT/US1995/012761 WO1996011933A1 (en) | 1994-10-14 | 1995-10-03 | Fused pyrrolocarbazoles |
US9512761 | 1995-10-03 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI971479A0 FI971479A0 (fi) | 1997-04-09 |
FI971479A FI971479A (fi) | 1997-06-11 |
FI115911B true FI115911B (fi) | 2005-08-15 |
Family
ID=27502273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI971479A FI115911B (fi) | 1994-10-14 | 1997-04-09 | Fuusioidut pyrrolokarbatsolit, menetelmä niiden valmistamiseksi ja niiden käyttö |
Country Status (17)
Country | Link |
---|---|
US (1) | US5705511A (pt) |
EP (2) | EP0785938B1 (pt) |
JP (1) | JP2001509775A (pt) |
AT (2) | ATE211472T1 (pt) |
AU (1) | AU705306B2 (pt) |
BR (1) | BR9509348A (pt) |
CA (1) | CA2202487C (pt) |
DE (2) | DE69524882T2 (pt) |
DK (2) | DK1088823T3 (pt) |
ES (2) | ES2235769T3 (pt) |
FI (1) | FI115911B (pt) |
HK (1) | HK1036622A1 (pt) |
MX (1) | MX9702682A (pt) |
NO (1) | NO308996B1 (pt) |
NZ (1) | NZ296244A (pt) |
PT (2) | PT785938E (pt) |
WO (1) | WO1996011933A1 (pt) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5808060A (en) * | 1995-12-11 | 1998-09-15 | Cephalon, Inc. | Fused isoindolones |
SE9603283D0 (sv) * | 1996-09-10 | 1996-09-10 | Astra Ab | New compounds |
JP2001515032A (ja) * | 1997-08-15 | 2001-09-18 | セフアロン・インコーポレーテツド | 前立腺がんを治療するためのチロシンキナーゼ阻害剤と化学的去勢術の組み合わせ法 |
CA2245029A1 (en) | 1998-03-13 | 1999-09-13 | University Of British Columbia | Granulatimide compounds as g2 checkpoint inhibitors |
DE69911935T3 (de) * | 1998-03-13 | 2008-02-07 | The University Of British Columbia, Vancouver | Granulatimide-derivate zur behandlung von krebs |
US6811992B1 (en) | 1998-05-14 | 2004-11-02 | Ya Fang Liu | Method for identifying MLK inhibitors for the treatment of neurological conditions |
US6127401A (en) | 1998-06-05 | 2000-10-03 | Cephalon, Inc. | Bridged indenopyrrolocarbazoles |
US7795246B2 (en) * | 1998-08-06 | 2010-09-14 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
US6200968B1 (en) | 1998-08-06 | 2001-03-13 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
BR9913190A (pt) * | 1998-08-26 | 2001-12-11 | Cephalon Inc | Modulação de proteìnas quinase de linhagemmúltipla |
AU763435B2 (en) * | 1998-09-25 | 2003-07-24 | Cephalon, Inc. | Methods for preventing/treating damage to sensory hair cells and cochlear neurons |
US6841567B1 (en) * | 1999-02-12 | 2005-01-11 | Cephalon, Inc. | Cyclic substituted fused pyrrolocarbazoles and isoindolones |
US6399780B1 (en) * | 1999-08-20 | 2002-06-04 | Cephalon, Inc. | Isomeric fused pyrrolocarbazoles and isoindolones |
GB0002952D0 (en) * | 2000-02-09 | 2000-03-29 | Pharma Mar Sa | Process for producing kahalalide F compounds |
US20060276497A1 (en) | 2000-05-09 | 2006-12-07 | Cephalon, Inc. | Novel multicyclic compounds and the use thereof |
US7122679B2 (en) | 2000-05-09 | 2006-10-17 | Cephalon, Inc. | Multicyclic compounds and the use thereof |
IL154311A0 (en) * | 2000-08-11 | 2003-09-17 | Cephalon Inc | Modulating multiple lineage kinase proteins |
US6630500B2 (en) * | 2000-08-25 | 2003-10-07 | Cephalon, Inc. | Selected fused pyrrolocarbazoles |
AU2001285205B2 (en) * | 2000-08-25 | 2007-03-01 | Cephalon, Inc. | Fused pyrrolocarbazoles against inflammation |
US6677450B2 (en) | 2000-10-06 | 2004-01-13 | Bristol-Myers Squibb Company | Topoisomerase inhibitors |
US6610727B2 (en) | 2000-10-06 | 2003-08-26 | Bristol-Myers Squibb Company | Anhydro sugar derivatives of indolocarbazoles |
US6653290B2 (en) * | 2000-10-06 | 2003-11-25 | Bristol-Myers Squibb Company | Tumor proliferation inhibitors |
RU2003131269A (ru) | 2001-03-22 | 2005-05-10 | Бристол-Маерс Сквибб Компани (Us) | Производные индолопирролокарбазолов и сахаров, цитотоксические и селективные по отношению к топоизомеразе i |
AR035971A1 (es) * | 2001-05-16 | 2004-07-28 | Cephalon Inc | Metodos para el tratamiento y la prevencion del dolor |
FR2826653B1 (fr) | 2001-06-29 | 2005-10-14 | Servier Lab | Nouveaux derives de pyrido-pyrido-pyrrolo[3,2-g]pyrrolo [3,4-e]-indole et pyrido-pyrrolo[2,3-a]pyrrolo[3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
IL144583A0 (en) | 2001-07-26 | 2002-05-23 | Peptor Ltd | Chimeric protein kinase inhibitors |
US20050054555A1 (en) * | 2001-10-19 | 2005-03-10 | Jose Jimeno | Kahalalide compounds for use in cancer therapy |
US7482134B2 (en) * | 2002-06-05 | 2009-01-27 | Seoul National University Industry Foundation | Signals and molecular species involved in senescence |
GB0304367D0 (en) * | 2003-02-26 | 2003-04-02 | Pharma Mar Sau | Methods for treating psoriasis |
FR2845997B1 (fr) * | 2002-10-18 | 2004-12-24 | Servier Lab | Nouveaux derives de[1,4]benzodioxino[2,3-e]isoindole substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US7507708B2 (en) * | 2003-02-26 | 2009-03-24 | Pharma Mar, S.A.U. | Antitumoral compounds |
WO2005014003A1 (en) * | 2003-07-23 | 2005-02-17 | Creabilis Therapeutics S.R.L. | Topical use of tyrosine kinase inhibitors of microbial origin to prevent and treat skin disorders characterised by excessive cell proliferation |
GB0321066D0 (en) * | 2003-09-09 | 2003-10-08 | Pharma Mar Sau | New antitumoral compounds |
US7169802B2 (en) * | 2003-12-23 | 2007-01-30 | Cephalon, Inc. | Fused pyrrolocarbazoles |
US7241779B2 (en) * | 2003-12-23 | 2007-07-10 | Cephalon, Inc. | Fused pyrrolocarbazoles |
MX2007001155A (es) * | 2004-07-29 | 2007-08-14 | Creabilis Therapeutics Spa | Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1. |
US20060058250A1 (en) * | 2004-09-10 | 2006-03-16 | Cephalon, Inc. | Methods of treating proliferative skin diseases using carbazole derivatives |
KR100734429B1 (ko) * | 2004-12-06 | 2007-07-03 | 재단법인서울대학교산학협력재단 | 노화에 관여하는 신호 및 분자종 |
US20060134176A1 (en) * | 2004-12-22 | 2006-06-22 | Bausch & Lomb Incorporated | Pharmaceutical delivery system and method of use |
US20060134175A1 (en) * | 2004-12-22 | 2006-06-22 | Stephen Bartels | Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use |
US20060134174A1 (en) * | 2004-12-22 | 2006-06-22 | Bausch & Lomb Incorporated | Pharmaceutical delivery system and method of use |
WO2007002670A2 (en) * | 2005-06-28 | 2007-01-04 | Bausch & Lomb Incorporated | Method of lowering intraocular pressure |
US20080199850A1 (en) | 2005-10-11 | 2008-08-21 | Merck Patent Gmbh | Egfr Dependent Modulation of Chemokine Expression and Influence on Therapy and Diagnosis of Tumors and Side Effects Thereof |
US20070249590A1 (en) * | 2005-10-28 | 2007-10-25 | Wilson Lawrence J | Substituted indolo[2,3-a]pyrrolo[3,4-c]carbazole compounds useful in treating kinase disorders |
US20080021013A1 (en) * | 2006-07-21 | 2008-01-24 | Cephalon, Inc. | JAK inhibitors for treatment of myeloproliferative disorders |
KR100831367B1 (ko) | 2007-02-16 | 2008-05-22 | 재단법인서울대학교산학협력재단 | 아데닐일 시클라아제의 억제제를 노화 세포에 처리하는 단계를 포함하는 세포의 노화 조절방법 및 아데닐일 시클라아제의 억제제를 포함하는 세포 노화 조절용 조성물 |
CN101861159A (zh) * | 2007-10-19 | 2010-10-13 | 马尔药品公司 | 改进的抗肿瘤治疗 |
US20090155352A1 (en) * | 2007-11-20 | 2009-06-18 | Cephalon, Inc. | Microemulsion containing indolocarbazole compound and dosage forms containing the same |
CA2932121A1 (en) * | 2007-11-30 | 2009-06-11 | Newlink Genetics Corporation | Ido inhibitors |
EP2367829B1 (en) * | 2008-11-19 | 2013-01-02 | Cephalon, Inc. | Novel forms of an indazolo [5,4-a] pyrrolo [3,4-c] carbazole compound |
EP2192121A1 (en) | 2008-11-27 | 2010-06-02 | Cephalon France | Regioselective reduction of fused pyrrolocarbazoles-5,7-diones |
CN102482279B (zh) | 2009-03-30 | 2015-08-12 | 德山新勒克斯 | 有机电子装置及其化合物与终端机 |
KR101182438B1 (ko) * | 2009-08-14 | 2012-09-12 | 삼성디스플레이 주식회사 | 유기 발광 소자 |
US20150320861A1 (en) | 2012-12-21 | 2015-11-12 | Sykehuset Sørlandet Hf | Egfr targeted therapy of neurological disorders and pain |
JP2020506895A (ja) | 2017-01-17 | 2020-03-05 | ボード オブ レジェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System | インドールアミン2,3−ジオキシゲナーゼおよび/またはトリプトファンジオキシゲナーゼの阻害剤として有用な化合物 |
DE102017117328A1 (de) * | 2017-07-31 | 2019-01-31 | Mitsubishi Polyester Film Gmbh | Peelfähige Polyesterfolie, Verfahren zu ihrer Herstellung und ihre Verwendung |
WO2020018670A1 (en) | 2018-07-17 | 2020-01-23 | Board Of Regents, The University Of Texas System | Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4552842A (en) * | 1983-01-28 | 1985-11-12 | Bristol-Myers Company | Process for producing rebeccamycin |
DE3752123T2 (de) * | 1987-03-09 | 1998-05-14 | Kyowa Hakko Kogyo Kk | Derivate des physiologisch aktiven mittels k-252 |
DE3835842A1 (de) * | 1988-10-21 | 1990-04-26 | Goedecke Ag | Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel |
NZ227850A (en) * | 1988-02-10 | 1991-11-26 | Hoffmann La Roche | Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders |
DE3833008A1 (de) * | 1988-09-29 | 1990-04-05 | Goedecke Ag | Pyrrolocarbozol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel |
MC2096A1 (fr) * | 1989-02-23 | 1991-02-15 | Hoffmann La Roche | Pyrroles substitues |
US5185260A (en) * | 1991-08-29 | 1993-02-09 | The United States Of America As Represented By The United States Department Of Energy | Method for distinguishing normal and transformed cells using G1 kinase inhibitors |
NZ245203A (en) * | 1991-11-29 | 1997-07-27 | Banyu Pharma Co Ltd | 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates |
US6271242B1 (en) * | 1992-02-10 | 2001-08-07 | Bristol-Myers Squibb Co. | Method for treating cancer using a tyrosine protein kinase inhibitor |
US5405864A (en) * | 1993-10-15 | 1995-04-11 | Syntex (U.S.A.) Inc. | Chemotherapeutic maleimides |
DE4337521A1 (de) * | 1993-11-03 | 1995-05-04 | Teves Gmbh Alfred | Verfahren zur Funktionsprüfung eines hydraulischen Aggregats |
-
1995
- 1995-09-11 US US08/526,798 patent/US5705511A/en not_active Expired - Lifetime
- 1995-10-03 AT AT95938713T patent/ATE211472T1/de active
- 1995-10-03 DE DE69524882T patent/DE69524882T2/de not_active Expired - Lifetime
- 1995-10-03 NZ NZ296244A patent/NZ296244A/en not_active IP Right Cessation
- 1995-10-03 MX MX9702682A patent/MX9702682A/es unknown
- 1995-10-03 AT AT00204170T patent/ATE286055T1/de active
- 1995-10-03 EP EP95938713A patent/EP0785938B1/en not_active Expired - Lifetime
- 1995-10-03 WO PCT/US1995/012761 patent/WO1996011933A1/en active IP Right Grant
- 1995-10-03 ES ES00204170T patent/ES2235769T3/es not_active Expired - Lifetime
- 1995-10-03 JP JP51328996A patent/JP2001509775A/ja not_active Ceased
- 1995-10-03 ES ES95938713T patent/ES2170812T3/es not_active Expired - Lifetime
- 1995-10-03 PT PT95938713T patent/PT785938E/pt unknown
- 1995-10-03 EP EP00204170A patent/EP1088823B1/en not_active Expired - Lifetime
- 1995-10-03 BR BR9509348A patent/BR9509348A/pt not_active IP Right Cessation
- 1995-10-03 DE DE69533899T patent/DE69533899T2/de not_active Expired - Lifetime
- 1995-10-03 AU AU39986/95A patent/AU705306B2/en not_active Expired
- 1995-10-03 DK DK00204170T patent/DK1088823T3/da active
- 1995-10-03 DK DK95938713T patent/DK0785938T3/da active
- 1995-10-03 PT PT00204170T patent/PT1088823E/pt unknown
- 1995-10-03 CA CA002202487A patent/CA2202487C/en not_active Expired - Lifetime
-
1997
- 1997-04-09 FI FI971479A patent/FI115911B/fi not_active IP Right Cessation
- 1997-04-11 NO NO971677A patent/NO308996B1/no not_active IP Right Cessation
-
2001
- 2001-10-04 HK HK01106989A patent/HK1036622A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE286055T1 (de) | 2005-01-15 |
ATE211472T1 (de) | 2002-01-15 |
FI971479A (fi) | 1997-06-11 |
NO971677D0 (no) | 1997-04-11 |
ES2235769T3 (es) | 2005-07-16 |
FI971479A0 (fi) | 1997-04-09 |
US5705511A (en) | 1998-01-06 |
DK1088823T3 (da) | 2005-04-25 |
DE69524882D1 (de) | 2002-02-07 |
CA2202487A1 (en) | 1996-04-25 |
EP0785938A1 (en) | 1997-07-30 |
CA2202487C (en) | 2008-06-17 |
NZ296244A (en) | 1998-11-25 |
HK1036622A1 (en) | 2002-01-11 |
EP0785938B1 (en) | 2002-01-02 |
AU3998695A (en) | 1996-05-06 |
WO1996011933A1 (en) | 1996-04-25 |
JP2001509775A (ja) | 2001-07-24 |
DE69533899D1 (de) | 2005-02-03 |
DE69524882T2 (de) | 2002-09-12 |
ES2170812T3 (es) | 2002-08-16 |
DK0785938T3 (da) | 2002-04-22 |
DE69533899T2 (de) | 2005-12-08 |
EP1088823A1 (en) | 2001-04-04 |
BR9509348A (pt) | 1997-11-04 |
PT1088823E (pt) | 2005-03-31 |
NO971677L (no) | 1997-06-11 |
EP1088823B1 (en) | 2004-12-29 |
PT785938E (pt) | 2002-06-28 |
MX9702682A (es) | 1998-02-28 |
NO308996B1 (no) | 2000-11-27 |
AU705306B2 (en) | 1999-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI115911B (fi) | Fuusioidut pyrrolokarbatsolit, menetelmä niiden valmistamiseksi ja niiden käyttö | |
US5591855A (en) | Fused pyrrolocarbazoles | |
US5475110A (en) | Fused Pyrrolocarbazoles | |
US5594009A (en) | Fused pyrrolocarbazoles | |
JP4776842B2 (ja) | 異性体の縮合ピロロカルバゾール類およびイソインドロン類 | |
US6610684B2 (en) | Fused azepinone cyclin dependent kinase inhibitors | |
JP2021530442A (ja) | 縮合三環系複素環化合物およびその治療上の使用 | |
PL198434B1 (pl) | Nowe mostkowane indenopirolokarbazole, kompozycje farmaceutyczne zawierające te związki i ich zastosowanie | |
AU4376897A (en) | Novel indole-2,3-dione-3-oxime derivatives | |
JP3170584B2 (ja) | 新規なイサチンオキシム誘導体類、その製造および使用 | |
EP1756112A1 (en) | Pyrrolobenzimidazolones and their use as antiproliferative agents | |
WO2003057161A2 (en) | BENZOTHIENO [3,2-c]PYRAZOLYL AND BENZOFURANO [3,2-c] PYRAZOLYL COMPOUNDS, THEIR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR AND INTERMEDIATE COMPOUNDS THEREOF | |
KR100460783B1 (ko) | 폴리시클릭 아자인돌 화합물, 이들을 제조하는 방법 및이들을 함유하는 약제 조성물 | |
JP2006504632A (ja) | チェックポイントキナーゼ(Wee1およびChk1)の阻害剤 | |
Hénon et al. | Synthesis and biological evaluation of new dipyrrolo [3, 4-a: 3, 4-c] carbazole-1, 3, 4, 6-tetraones, substituted with various saturated and unsaturated side chains via palladium catalyzed cross-coupling reactions | |
US5808060A (en) | Fused isoindolones | |
CN101528230A (zh) | 作为钙通道阻断剂的吲哚并喹啉类化合物 | |
JP4070810B2 (ja) | タンパク質キナーゼcの阻害剤としての縮合イソインドロン | |
KR930001407B1 (ko) | 신규한 이소인돌 유도체 및 그의 염, 이의 제조방법 및 이를 포함하는 종양치료제 | |
JPH09208466A (ja) | 縮合多環式ヘテロ環誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 115911 Country of ref document: FI |
|
MA | Patent expired |